Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001453687-25-000074
Filing Date
2025-04-28
Accepted
2025-04-28 16:41:15
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A rnac_defa14a-2024notice.htm DEFA14A 15003
2 proxynotice1.jpg GRAPHIC 499191
3 proxynotice2.jpg GRAPHIC 372530
  Complete submission text file 0001453687-25-000074.txt   1216255
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37798 | Film No.: 25881114
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)